Oncology Today with Dr Neil Love
Oncology Today with Dr Neil Love
✓

Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies

· Mostrar notas
00:47:06
Podcasts
RSS
Link

SOBRE ESTE EPISÓDIO

Featuring an interview with Dr L Elizabeth Budde, including the following topics:

  • Considerations for selecting between bispecific antibodies (BsAbs); monotherapy versus combination therapy (0:00)
  • Management of BsAb-induced cytokine release syndrome and other toxicities (7:35)
  • Use of BsAbs in the front-line treatment of diffuse large B-cell lymphoma (DLBCL); key findings from the Phase II MorningSun study (17:30)
  • Case: A man in his mid 50s with relapsed/refractory (R/R) DLBCL receives mosunetuzumab and polatuzumab vedotin in the second-line setting (23:18)
  • Case: A woman in her early 70s with R/R DLBCL receives glofitamab monotherapy in the third-line setting (32:52)
  • Case: A man in his early 80s with R/R DLBCL experiences disease progression after lisocabtagene maraleucel therapy, which was bridged with epcoritamab and gemcitabine/oxaliplatin (37:35)

CME information and select publications

Medicina
Educação
Saúde e fitness
Medicina
Ciência
Inglês
Estados Unidos da América
UseAPIpara buscar este episódio emJSON

NESTE EPISÓDIO

Editar estas etiquetas

MOSTRAR NOTAS 🔗

00:00:00Considerations for selecting between bispecific antibodies (BsAbs); monotherapy versus combination therapy
00:07:35Management of BsAb-induced cytokine release syndrome and other toxicities
00:17:30Use of BsAbs in the front-line treatment of diffuse large B-cell lymphoma (DLBCL); key findings from the Phase II MorningSun study
00:23:18Case: A man in his mid 50s with relapsed/refractory (R/R) DLBCL receives mosunetuzumab and polatuzumab vedotin in the second-line setting
00:32:52Case: A woman in her early 70s with R/R DLBCL receives glofitamab monotherapy in the third-line setting
00:37:35Case: A man in his early 80s with R/R DLBCL experiences disease progression after lisocabtagene maraleucel therapy, which was bridged with epcoritamab and gemcitabine/oxaliplatin

TRANSCRIÇÃO 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

PESQUISAR EPISÓDIOS PASSADOS

Pesquisar episódios anteriores de Oncology Today with Dr Neil Love.
Incorpore esta barra de pesquisa ao seu site

OUTROS EPISÓDIOS NESTE PODCAST

Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 3 with Dr Sara M Tolaney

Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 3 with Dr Sara M Tolaney

Featuring perspectives from Dr Sara M Tolaney, including the following topics: Mechanistic effects and potential resistance mechanisms of antibody-drug conjugates (0:00) First-line treatment of metastatic triple-negative breast cancer (mTNBC) in patients eligible for immunotherapy (7:13) First-lin…
00:25:05
PARTILHAR
GUARDAR
Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Featuring perspectives from Dr Stephen V Liu and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: Introduction (0:00) EGFR Mutations (2:23) HER2 Alterations (22:40) Available and Investigational Immunotherapies (32:14) Small Cell Lung Cancer (40:48) CME information…
00:50:33
PARTILHAR
GUARDAR
Chronic Lymphocytic Leukemia — Investigators Discuss Optimal Management

Chronic Lymphocytic Leukemia — Investigators Discuss Optimal Management

Featuring perspectives from Dr Catherine C Coombs and Dr Matthew S Davids, including the following topics: Introduction (0:00) Minimal Residual Disease Assays in Community-Based Practice (1:24) New Developments in Previously Untreated Chronic Lymphocytic Leukemia (CLL) — Dr Davids (8:12) Richter T…
00:58:15
PARTILHAR
GUARDAR
HER2-Positive Gynecologic Cancers — Microlearning Activity 3: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

HER2-Positive Gynecologic Cancers — Microlearning Activity 3: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

Featuring perspectives from Dr Joyce F Liu, Dr David M O'Malley and Dr Brian M Slomovitz, moderated by Dr O'Malley, including the following topics: Case: A woman in her mid 60s with Stage II uterine carcinosarcoma treated with surgery followed by paclitaxel/carboplatin, whole-pelvic radiation and …
00:13:57
PARTILHAR
GUARDAR
Aviso: O podcast e a arte incorporada nesta página são de Dr. Neil Love, que é propriedade de seu proprietário e não é afiliado ou endossado por Listen Notes, Inc.
PROMOTED
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
PodcastAPI.com

RECOMENDAÇÕES
Use a API para ir buscar este episódio